Search

Author/Creator Boni, V.

1. 304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRI. (September 2015)

Authors:
Nayak, T.; Massard, C.; Martinez Garcia, M.; Le Tourneau, C.; Boni, V.; Garralda, E.; Taus, A.; Albanell, J.; Lahr, A.; Krieter, O.; Hidalgo, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 335 Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors. (September 2015)

Authors:
Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; Varghese, A.M.; Jimenez, E.; Luque, J.; Soto-Matos, A.; Szyldergemajn, S.; Sessa, C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 361 Phase I, open-label, dose-escalating clinical and pharmacokinetic study of the novel antimicrotubulin agent PM060184 administered over 10 minutes on days 1-3 and 15-17 every 28 days to patients with advanced malignant solid tumors. (September 2015)

Authors:
Hidalgo, M.; Boni, V.; Tolcher, A.; Smith, L.; Cubillo, A.; Rasco, D.; Calvo, E.; Amaya, A.; Ordoñez, E.; Patnaik, A.; Cerda, S.; Coronado, C.; Fudio, S.; Miguel-Lillo, B.; Prados, R.; Ortega, O.; Soto-Matos, A.; Papadopoulos, K.P.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 431 Biomarkers related to Vanucizumab single agent therapy in serial plasma, tumor tissue and skin wound-healing biopsies of patients with advanced solid tumors. (September 2015)

Authors:
Babitzki, G.; Hidalgo, M.; Massard, C.; Garcia, M. Martinez; Tourneau, C. Le; Boni, V.; Mestres, J. Albanell; Garcia, A. Taus; Alt, M.; Sablin, M.P.; Gerber, P.; Krieter, O.; Lahr, A.; Palme, S.; Rossomanno, S.; Harring, S. Vega; Wild, N.; Zajac, M.; Lechner, K.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors. (October 2022)

Authors:
Dziadziuszko, R.; Garralda Cabanas, E.; Rojas, K.; Chelstowska, M.; Blaszkowska, M.; Dudziak, R.; Rzymski, T.; Angelosanto, N.; Littlewood, P.; Nogai, H.; Boni, V.; Lugowska, I.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗